Skip to content

Clinical trials

Terminated Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Terminated Country / region: Italy Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20121
20141
20151
20162
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Gruppo Italiano Malattie EMatologiche dell'Adulto2
Ariad Pharmaceuticals1
Bristol-Myers Squibb1
Incyte Corporation1
Pfizer1
Sun Pharma Advanced Research Company Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive10
Leukemia3
Leukemia, Myeloid, Chronic-Phase3
Bone Marrow Diseases2
Hematologic Neoplasms2
Leukemia, Myeloid2
Anemia, Refractory, with Excess of Blasts1
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1
Hematologic Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.